Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Stem Cell
SUBMITTER: Rui Vitorino
LAB HEAD: Bruno Jesus
PROVIDER: PXD033005 | Pride | 2025-06-23
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
2021MQ038_BRBE_001_01_1ug.raw | Raw | |||
2021MQ038_BRBE_002_01_1ug.raw | Raw | |||
2021MQ038_BRBE_003_01_1ug.raw | Raw | |||
2021MQ038_BRBE_004_01_1ug.raw | Raw | |||
2021MQ038_BRBE_005_01_1ug.raw | Raw |
Items per page: 5 1 - 5 of 14 |
Correia Magda M Tavares-Marcos Carlota C Pessoa João J Casanova Miguel M Cavadas Bruno B Vitorino Rui R Tavares E Silva Júlia J Mateus Francisca F Espadas Guadalupe G Pinheiro Mariana M Alves-Vale Catarina C Sabidó Eduard E Neves Bruno B Nóbrega-Pereira Sandrina S Bernardes de Jesus Bruno B
iScience 20250516 6
Stem cells are emerging sources of antigens for cancer immunotherapy. Here, we used TNG-A mouse embryonic stem cells to trigger an anticancer response against tumors derived from E0771 mouse breast cancer cells, possibly mediated by the mouse immune system. TNG-A cells were cultured in the presence or absence of two specific kinase inhibitors. While the inhibitors preserved TNG-A pluripotency, their removal altered the morphology, transcriptome, and proteome of TNG-A cells, increasing their simi ...[more]